Table 1.
Total number of biosimilars approved until 2023 by the eight countries analyzed.
Countries and Sources | Total Number Approved | Regulatory Framework for Biosimilars |
---|---|---|
Canada [134] | 53 (September 2023) | CMA |
Brazil [135] | 52 (May 2023) | ANVISA |
United States [136] | 45 (December 2023) | FDA |
Australia [137] | 43 (September 2023) | TGA |
Japan [138] | 32 (December 2022) | PMDA |
South Korea [108] | 25 (December 2022) | MFDS |
Argentina [126] | 24 (December 2022) | ANMAT |
South Africa [139] | 5 (November 2020) | SAHPRA |